The Globalists’ In Plain Sight Host Christine Dolan continues to cover ALL THINGS PFIZER with Sasha Latypova. This week the focus is PFIZER, miscarriages, still born and fertility.
Going forward CDMedia will be collaborating with Sasha Latypova to bring to light everything about PHARMA connected to COVID-19.
Latypova experience spans 25 years in PHARMA R&D, technology and data analysis. She has worked in econometrics and litigation support for PHARMA and healthcare clients.
Latypova has worked on 100’s of clinical trials for about 60 PHARMA companies globally and worked with Pfizer extensively as a client and an investor up to approximately 2013. Between 2006 -2017 her focus was on cardiovascular safety assessments for new drugs, and has interacted with the FDA, and co-led an industry-FDA consortium investigating new technologies.